ArticleEuropean clinical respiratory journal2025
Longitudinal impact of oral bacteria and endotoxin on lung function.
Article in European clinical respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic respiratory diseases are on the rise globally, and growing evidence shows that lungs whether healthy or diseased harbor bacterial communities that primarily originate from the oral cavity. Despite this, longitudinal studies examining how oral bacteria influence respiratory health trajectories in the general population are lacking. Aim: This study aimed to explore the influence of oral bacteria on lung function (LF) outcomes measured 6 years later in a community-based Norwegian population. Analyses included measurements of endotoxin load and lipid A profiling to assess the inflammatory potential of oral bacterial communities. Methods: Saliva samples and spirometry data were collected from 75 participants in the RHINESSA study (Bergen, Norway) at baseline (2014-2015). Spirometry was repeated at follow-up (2020-2021). Bacterial community composition and endotoxin lipid A profiling were determined by targeted sequencing of the 16S rRNA gene (V3-V4 region). Associations between baseline salivary microbiota and lung function at follow-up were assessed using multivariate linear regression. Results: The relative abundance of Conclusions: Salivary bacterial community characteristics were associated with LF outcomes measured 6 years later. Our findings suggest that the oral microbiota may represent a potential target for disease prevention or intervention strategies, warranting further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.